医学
随机对照试验
早孕因素
健康指导
产科
怀孕
妊娠期糖尿病
物理疗法
妊娠期
干预(咨询)
妇科
产后
儿科
指导
高危妊娠
临床试验
子痫前期
胎龄
产妇保健
出生体重
妊娠高血压
梅德林
人口
生活质量(医疗保健)
作者
Sharleen L. O'Reilly,Fionnuala Mary McAuliffe,Helena Jane Teede,Christy Burden,Cristina Campoy,Helle Terkildsen Maindal,Cheryce L. Harrison,Anna K. Davies,Mercedes G Bermúdez,Rachel Laws,Vincent Lawrence Versace,Tesfaye Regassa Feyissa,Graham Lee,Paula O'Shea,Ditte Hjorth Laursen,Karsten Vrangbæk,Timothy Charles Skinner
标识
DOI:10.1016/j.landig.2026.101059
摘要
BACKGROUND: Maternal overweight and obesity increase the risk of gestational diabetes and adverse pregnancy outcomes. Digital health interventions offer scalable, personalised support, but evidence for interventions spanning both pregnancy and postpartum remains scarce. We evaluated the effectiveness of a personalised mobile health (mHealth) coaching intervention for females at increased risk of gestational diabetes. METHODS: This multicentre, randomised controlled trial conducted in Australia, Ireland, Spain, and the UK enrolled pregnant females aged 18 years and older between 12-24 weeks of gestation with increased risk of gestational diabetes (Monash GDM risk tool score ≥3; tool risk factors were maternal age, BMI, ethnicity, family history of diabetes, and past history of gestational diabetes). Participants were randomly assigned (1:1) using computer-generated block randomisation (block size 200; stratified by site) to receive either personalised mHealth coaching via smartphone providing synchronous and asynchronous support through pregnancy to 12 months postpartum alongside usual maternity care, or usual maternity care alone. Usual maternity care, including gestational diabetes screening and management, continued unchanged in both groups, and both groups received Bluetooth-enabled scales. Participants and health coaches could not be masked to allocation; clinical staff providing usual care, laboratory staff, and trial statisticians were masked. The primary outcome was the between-group mean difference in BMI at 12 months postpartum among females at risk of gestational diabetes. The trial was registered at Australia and New Zealand Clinical Trials Register, ACTRN12620001240932. FINDINGS: [0·13]). Adverse events were recorded in 18% (79 of 437) of participants in the intervention group and 25% (106 of 428) of participants in the control group; serious adverse events occurred in 6% (28 of 437) of participants in the intervention group and 9% (40 of 428) of participants in the control group. No adverse or serious adverse events were considered related to the intervention. INTERPRETATION: Personalised mHealth coaching spanning pregnancy and an extended postpartum support period did not reduce mean maternal BMI at 12 months compared with usual care. Findings suggest that mHealth interventions targeting at-risk females might benefit from addressing a broader range of maternal health outcomes beyond weight management. FUNDING: European Union Commission Horizon 2020 and National Health and Medical Research Council of Australia.
科研通智能强力驱动
Strongly Powered by AbleSci AI